Category

HIV/AIDS

People with HIV, LGBT people, and Black and Latino people would disproportionately lose health insurance under the Affordable Health Care Act

By | Health Care, Health Policy, HIV/AIDS, HIV/AIDS, LGBT Health, The Fenway Institute | No Comments
On May 24, the Congressional Budget Office (CBO) projected that the amended American Health Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result in 23 million Americans losing their health insurance by 2026 as compared with what would be expected under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). “It is clear from the CBO analysis that the amended Republican health care plan is no better than the original bill,” said Sean Cahill, Director of Health Policy Research at The Fenway Institute. “Of the 23 million Americans projected to lose their 
Read More

Volunteers Needed For New PrEP Study That Could Revolutionize HIV Prevention

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
Increased public awareness and use of pre-exposure prophylaxis (PrEP) has been tremendously powerful in the global battle against HIV/AIDS. Studies have shown that, when taken as a daily pill, PrEP is 92-99% effective at preventing HIV infections in HIV-negative individuals. However, as with any daily medication, strict adherence is the key to success – and, for many people, this may become a barrier to PrEP’s effectiveness. The Fenway Institute is serving as a site for a new study, HPTN 083, that explores whether injectable, long-acting PrEP, is a viable alternative to oral PrEP. Injectable PrEP has the potential to truly 
Read More

HIV Vaccines Could Vastly Improve HIV Prevention – And You Can Help

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
There were a reported 2.1 million new HIV infections in 2015, and 36.7 million people are currently living with HIV/AIDS globally. Vaccines could be an incredibly powerful tool in the fight against HIV/AIDS, with the potential to dramatically reduce the number of new HIV infections around the world. In continuation of Fenway Health’s decades-long commitment to treating and preventing HIV/AIDS, The Fenway Institute is excited to serve as a study site for several HIV vaccine trials, including HVTN 108. HVTN 108 will examine both tolerability of a new HIV vaccine and the immune system’s response to it. It’s important to 
Read More

Policy Changes May Expand Behavioral Health Care Access For People Living With HIV/AIDS

By | Behavioral Health, Fenway Health Newsroom, Health Policy, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Comprehensive behavioral health care is a key component of overall wellness. For people living with HIV (PLWH), access to these services is especially critical. The stress caused by pervasive stigma and discrimination around HIV/AIDS has been shown to contribute to a number of behavioral health problems, including depression, anxiety, psychological trauma, and substance abuse. The duel challenges of HIV and psychiatric diagnoses means that this population has unique behavioral health needs that must be integrated into culturally-competent care plans. A new brief from The National Center for Innovation in HIV Care at The Fenway Institute outlines recent changes in federal 
Read More

Help Shape The Future Of HIV Prevention: Join A Research Study Today

By | HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
The battle against HIV/AIDS has shifted dramatically in the past decade, as our understanding of the virus and how to combat it has increased. The introduction of Pre-Exposure Prophylaxis (PrEP), a daily pill commonly known as Truvada, has been an incredible game changer for HIV prevention. Currently, condom use and PrEP are the most proven effective methods for protection against HIV infection. “Using Truvada for PrEP has been revolutionary for HIV prevention, but, unfortunately, it’s not a one size fits all solution,” said Ryan Tappin, Clinical Manager, Biomedical Research at The Fenway Institute. “The more choices for PrEP that patients 
Read More